InsiderClue
Insiders · Profile

BISCHOFBERGER NORBERT W

EVP, R&D and CSO at Gilead Sciences. Filing since 25 Oct 2006. CIK 0001190273

Company
Date
Role
Action
Shares
Amount
Of holding
GILD Gilead Sciences
15 Dec 2015
EVP, R&D and CSO
Sold, plan not stated
70,000
$7.17M
35.4%
GILD Gilead Sciences
16 Nov 2015
EVP, R&D and CSO
Sold, plan not stated
70,000
$7.19M
29.8%
GILD Gilead Sciences
15 Oct 2015
EVP, R&D and CSO
Sold, plan not stated
70,000
$7.00M
29.8%
GILD Gilead Sciences
15 Sep 2015
EVP, R&D and CSO
Sold, plan not stated
70,000
$7.75M
29.8%
GILD Gilead Sciences
17 Aug 2015
EVP, R&D and CSO
Sold, plan not stated
70,000
$8.13M
29.8%
GILD Gilead Sciences
15 Jul 2015
EVP, R&D and CSO
Sold, plan not stated
66,261
$7.83M
28.2%
GILD Gilead Sciences
7 Jul 2015
EVP, R&D and CSO
Sold, plan not stated
3,739
$446.40K
2.2%
GILD Gilead Sciences
15 Jun 2015
EVP, R&D and CSO
Sold, plan not stated
70,000
$8.24M
29.8%
GILD Gilead Sciences
15 May 2015
EVP, R&D and CSO
Sold, plan not stated
70,000
$7.66M
29.8%
GILD Gilead Sciences
15 Apr 2015
EVP, R&D and CSO
Sold, plan not stated
70,000
$7.27M
29.8%
GILD Gilead Sciences
16 Mar 2015
EVP, R&D and CSO
Sold, plan not stated
70,000
$7.06M
29.8%
GILD Gilead Sciences
17 Feb 2015
EVP, R&D and CSO
Sold, plan not stated
70,000
$7.21M
29.8%
GILD Gilead Sciences
15 Jan 2015
EVP, R&D and CSO
Sold, plan not stated
70,000
$6.89M
37.0%
GILD Gilead Sciences
16 Jun 2014
EVP, R&D and CSO
Sold, plan not stated
90,000
$7.28M
43.0%
GILD Gilead Sciences
14 May 2014
EVP, R&D and CSO
Sold, plan not stated
90,000
$7.26M
43.0%
GILD Gilead Sciences
14 Apr 2014
EVP, R&D and CSO
Sold, plan not stated
90,000
$6.03M
43.0%
GILD Gilead Sciences
14 Mar 2014
EVP, R&D and CSO
Sold, plan not stated
90,000
$6.83M
43.0%
GILD Gilead Sciences
14 Feb 2014
EVP, R&D and CSO
Sold, plan not stated
90,000
$7.32M
56.9%
GILD Gilead Sciences
14 Jan 2014
EVP, R&D and CSO
Sold, plan not stated
90,000
$6.68M
100%
GILD Gilead Sciences
16 Dec 2013
EVP, R&D and CSO
Sold, plan not stated
90,000
$6.46M
100%
GILD Gilead Sciences
14 Nov 2013
EVP, R&D and CSO
Sold, plan not stated
90,000
$6.20M
100%
GILD Gilead Sciences
14 Oct 2013
EVP, R&D and CSO
Sold, plan not stated
90,000
$5.63M
4.0%
GILD Gilead Sciences
16 Sep 2013
EVP, R&D and CSO
Sold, plan not stated
90,000
$5.68M
4.0%
GILD Gilead Sciences
14 Aug 2013
EVP, R&D and CSO
Sold, plan not stated
90,000
$5.29M
4.0%
GILD Gilead Sciences
15 Jul 2013
EVP, R&D and CSO
Sold, plan not stated
90,000
$5.16M
4.0%
GILD Gilead Sciences
24 Feb 2010
EVP, R&D and CSO
Sold, plan not stated
53,754
$2.55M
4.9%
GILD Gilead Sciences
12 Nov 2009
EVP, R&D and CSO
Sold, plan not stated
47,920
$2.25M
4.4%
GILD Gilead Sciences
12 Nov 2009
EVP, R&D and CSO
Sold, plan not stated
2,000
$94.32K
13.9%
GILD Gilead Sciences
24 Jul 2009
EVP, R&D and CSO
Sold, plan not stated
180,448
$8.66M
14.7%
GILD Gilead Sciences
21 May 2009
EVP, R&D and CSO
Sold, plan not stated
100,000
$4.26M
8.4%
GILD Gilead Sciences
21 May 2009
EVP, R&D and CSO
Sold, plan not stated
30,000
$1.28M
67.6%
GILD Gilead Sciences
4 Feb 2009
EVP, R&D and CSO
Sold, plan not stated
173,452
$9.10M
13.9%
GILD Gilead Sciences
7 Nov 2008
EVP, R&D and CSO
Sold, plan not stated
150,000
$6.77M
12.2%
GILD Gilead Sciences
7 Nov 2008
EVP, R&D and CSO
Sold, plan not stated
40,000
$1.79M
44.7%
GILD Gilead Sciences
24 Jul 2008
EVP, R&D and CSO
Sold, plan not stated
150,000
$7.81M
12.2%
GILD Gilead Sciences
24 Jul 2008
EVP, R&D and CSO
Sold, plan not stated
30,000
$1.56M
25.1%
GILD Gilead Sciences
30 Apr 2008
EVP, R&D and CSO
Sold, plan not stated
150,000
$7.81M
12.2%
GILD Gilead Sciences
30 Apr 2008
EVP, R&D and CSO
Sold, plan not stated
30,000
$1.56M
20.1%
GILD Gilead Sciences
8 Feb 2008
EVP, R&D and CSO
Sold, plan not stated
158,820
$7.06M
13.0%
GILD Gilead Sciences
26 Oct 2007
EVP, Research
Sold, plan not stated
220,000
$10.14M
17.6%
GILD Gilead Sciences
2 May 2007
EVP, Research
Sold, plan not stated
120,000
$10.06M
18.6%
GILD Gilead Sciences
9 Feb 2007
EVP, Research
Sold, plan not stated
133,920
$9.54M
20.3%
GILD Gilead Sciences
25 Oct 2006
EVP, Research
Sold, plan not stated
140,000
$9.50M
21.2%
43 decisions on file.